1.Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback.
Hyung Geun MOON ; Chil Sung KANG ; Jun Pyo CHOI ; Dong Sic CHOI ; Hyun Il CHOI ; Yong Wook CHOI ; Seong Gyu JEON ; Joo Yeon YOO ; Myoung Ho JANG ; Yong Song GHO ; Yoon Keun KIM
Experimental & Molecular Medicine 2013;45(1):e5-
T-helper (Th)17 cell responses are important for the development of neutrophilic inflammatory disease. Recently, we found that acetyl salicylic acid (ASA) inhibited Th17 airway inflammation in an asthma mouse model induced by sensitization with lipopolysaccharide (LPS)-containing allergens. To investigate the mechanism(s) of the inhibitory effect of ASA on the development of Th17 airway inflammation, a neutrophilic asthma mouse model was generated by intranasal sensitization with LPS plus ovalbumin (OVA) and then challenged with OVA alone. Immunologic parameters and airway inflammation were evaluated 6 and 48 h after the last OVA challenge. ASA inhibited the production of interleukin (IL)-17 from lung T cells as well as in vitro Th17 polarization induced by IL-6. Additionally, ASA, but not salicylic acid, suppressed Th17 airway inflammation, which was associated with decreased expression of acetyl-STAT3 (downstream signaling of IL-6) in the lung. Moreover, the production of IL-6 from inflammatory cells, induced by IL-17, was abolished by treatment with ASA, whereas that induced by LPS was not. Altogether, ASA, likely via its acetyl moiety, inhibits Th17 airway inflammation by blockade of IL-6 and IL-17 positive feedback.
Animals
;
Aspirin/pharmacology/*therapeutic use
;
Cell Polarity/drug effects/immunology
;
Feedback, Physiological/*drug effects
;
Interferon-gamma/deficiency/metabolism
;
Interleukin-17/*metabolism/pharmacology
;
Interleukin-6/biosynthesis/*metabolism
;
Lipopolysaccharides/pharmacology
;
Lung/drug effects/metabolism/pathology
;
Mice
;
Mice, Inbred C57BL
;
Pneumonia/*drug therapy/*immunology/pathology
;
Th17 Cells/drug effects/*immunology/pathology
;
Transforming Growth Factor beta1/pharmacology
2.Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro.
Xiao-li LIU ; Jing SONG ; Ke-jian LIU ; Wen-peng WANG ; Chang XU ; Yu-zeng ZHANG ; Yun LIU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):712-715
Skeletal fluorosis is a chronically metabolic bone disease with extensive hyperostosis osteosclerosis caused by long time exposure to fluoride. Skeletal fluorosis brings about a series of abnormal changes of the extremity, such as joint pain, joint stiffness, bone deformity, etc. Differentiation and maturation of osteoblasts were regulated by osteoclasts via Sema4D/Plexin-B1 signaling pathway. Furthermore, the differentiation and maturation of osteoclasts are conducted by osteoblasts via RANKL/RANK/OPG pathway. Both of these processes form a feedback circuit which is a key link in skeletal fluorosis. In this study, an osteoblast-osteoclast co-culture model in vitro was developed to illustrate the mechanism of skeletal fluorosis. With the increase of fluoride concentration, the expression level of Sema4D was decreased and TGF-β1 was increased continuously. OPG/RANKL mRNA level, however, increased gradually. On the basis of that, the inhibition of Sema4D/Plexin-B1/RhoA/ROCK signaling pathway caused by fluoride promoted the level of TGF-β1 and activated the proliferation of osteoblasts. In addition, osteroprotegerin (OPG) secreted by osteoblasts was up-regulated by fluoride. The competitive combination of OPG and RANKL was strengthened and the combination of RANKL and RANK was hindered. And then the differentiation and maturation of osteoclasts were inhibited, and bone absorption was weakened, leading to skeletal fluorosis.
Animals
;
Antigens, CD
;
genetics
;
metabolism
;
Cell Proliferation
;
drug effects
;
Feedback, Physiological
;
Fetus
;
Fluorides
;
pharmacology
;
GTPase-Activating Proteins
;
genetics
;
metabolism
;
Gene Expression Regulation, Developmental
;
Osteoblasts
;
drug effects
;
metabolism
;
pathology
;
Osteoclasts
;
drug effects
;
metabolism
;
pathology
;
Osteogenesis
;
drug effects
;
genetics
;
Osteoprotegerin
;
genetics
;
metabolism
;
RANK Ligand
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
metabolism
;
Rats
;
Receptor Activator of Nuclear Factor-kappa B
;
genetics
;
metabolism
;
Receptors, Cell Surface
;
genetics
;
metabolism
;
Semaphorins
;
genetics
;
metabolism
;
Signal Transduction
;
Transforming Growth Factor beta1
;
genetics
;
metabolism
;
rho-Associated Kinases
;
genetics
;
metabolism
;
rhoA GTP-Binding Protein
;
genetics
;
metabolism